344 related articles for article (PubMed ID: 21505189)
1. Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells.
Caccamo N; La Mendola C; Orlando V; Meraviglia S; Todaro M; Stassi G; Sireci G; Fournié JJ; Dieli F
Blood; 2011 Jul; 118(1):129-38. PubMed ID: 21505189
[TBL] [Abstract][Full Text] [Related]
2. IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17.
Moens E; Brouwer M; Dimova T; Goldman M; Willems F; Vermijlen D
J Leukoc Biol; 2011 May; 89(5):743-52. PubMed ID: 21330350
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation.
Devilder MC; Maillet S; Bouyge-Moreau I; Donnadieu E; Bonneville M; Scotet E
J Immunol; 2006 Feb; 176(3):1386-93. PubMed ID: 16424165
[TBL] [Abstract][Full Text] [Related]
4. In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands.
Poccia F; Malkovsky M; Pollak A; Colizzi V; Sireci G; Salerno A; Dieli F
Mol Med; 1999 Jul; 5(7):471-6. PubMed ID: 10449808
[TBL] [Abstract][Full Text] [Related]
5. Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells.
Meraviglia S; Caccamo N; Salerno A; Sireci G; Dieli F
J Immunol; 2010 Aug; 185(3):1770-6. PubMed ID: 20592281
[TBL] [Abstract][Full Text] [Related]
6. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
[TBL] [Abstract][Full Text] [Related]
7. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells.
Domae E; Hirai Y; Ikeo T; Goda S; Shimizu Y
Oncotarget; 2017 Jul; 8(28):45928-45942. PubMed ID: 28521284
[TBL] [Abstract][Full Text] [Related]
9. Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection.
Davey MS; Lin CY; Roberts GW; Heuston S; Brown AC; Chess JA; Toleman MA; Gahan CG; Hill C; Parish T; Williams JD; Davies SJ; Johnson DW; Topley N; Moser B; Eberl M
PLoS Pathog; 2011 May; 7(5):e1002040. PubMed ID: 21589907
[TBL] [Abstract][Full Text] [Related]
10. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells.
Haas JD; González FH; Schmitz S; Chennupati V; Föhse L; Kremmer E; Förster R; Prinz I
Eur J Immunol; 2009 Dec; 39(12):3488-97. PubMed ID: 19830744
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.
Martin B; Hirota K; Cua DJ; Stockinger B; Veldhoen M
Immunity; 2009 Aug; 31(2):321-30. PubMed ID: 19682928
[TBL] [Abstract][Full Text] [Related]
12. Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22.
Raifer H; Mahiny AJ; Bollig N; Petermann F; Hellhund A; Kellner K; Guralnik A; Reinhard K; Bothur E; Huber M; Bauer S; Löhning M; Kiss EA; Ganal SC; Diefenbach A; Korn T; Lohoff M
Eur J Immunol; 2012 Dec; 42(12):3189-201. PubMed ID: 22961652
[TBL] [Abstract][Full Text] [Related]
13. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen.
Lafont V; Liautard J; Liautard JP; Favero J
J Immunol; 2001 Jun; 166(12):7190-9. PubMed ID: 11390467
[TBL] [Abstract][Full Text] [Related]
14. Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vgamma9Vdelta2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons.
Boullier S; Poquet Y; Debord T; Fournie JJ; Gougeon ML
Eur J Immunol; 1999 Jan; 29(1):90-9. PubMed ID: 9933090
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 activates Vγ9Vδ2
Murday AS; Chaudhry S; Pauza CD
Immunology; 2017 Aug; 151(4):385-394. PubMed ID: 28342224
[TBL] [Abstract][Full Text] [Related]
16. Skewed representation of functionally distinct populations of Vgamma9Vdelta2 T lymphocytes in aging.
Re F; Poccia F; Donnini A; Bartozzi B; Bernardini G; Provinciali M
Exp Gerontol; 2005; 40(1-2):59-66. PubMed ID: 15664733
[TBL] [Abstract][Full Text] [Related]
17. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
[TBL] [Abstract][Full Text] [Related]
18. CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes.
DeBarros A; Chaves-Ferreira M; d'Orey F; Ribot JC; Silva-Santos B
Eur J Immunol; 2011 Jan; 41(1):195-201. PubMed ID: 21182090
[TBL] [Abstract][Full Text] [Related]
19. Two distinct populations of bovine IL-17⁺ T-cells can be induced and WC1⁺IL-17⁺γδ T-cells are effective killers of protozoan parasites.
Peckham RK; Brill R; Foster DS; Bowen AL; Leigh JA; Coffey TJ; Flynn RJ
Sci Rep; 2014 Jun; 4():5431. PubMed ID: 24961164
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.
Izumi T; Kondo M; Takahashi T; Fujieda N; Kondo A; Tamura N; Murakawa T; Nakajima J; Matsushita H; Kakimi K
Cytotherapy; 2013 Apr; 15(4):481-91. PubMed ID: 23391461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]